Investors focused on the Computer and Technology space have likely heard of Limelight Networks (LLNW), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.
The Industrial Products group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Altra Industrial Motion (AIMC) is a stock that can certainly grab the attention of many investors, but do its recent returns compare
For those looking to find strong Computer and Technology stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Synaptics (SYNA) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to th
Investors focused on the Medical space have likely heard of Eli Lilly and (LLY), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.
Investors focused on the Retail-Wholesale space have likely heard of Amazon.com (AMZN), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.
The following are today's upgrades for Validea's Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
The following are today's upgrades for Validea's Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade at a discount relative to their earnings growth and dividend yield.
The following are today's upgrades for Validea's Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth, reasonable valuations and low debt.
The following are today's upgrades for Validea's Book/Market Investor model based on the published strategy of Joseph Piotroski. This value-quant strategy screens for high book-to-market stocks, and then separates out financially sound firms by looking at a host of improving f
The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.
The following are today's upgrades for Validea's Growth/Value Investor model based on the published strategy of James P. O'Shaughnessy. This two strategy approach offers a large-cap value model and a growth approach that looks for persistent earnings growth and strong relative
The following are today's upgrades for Validea's Contrarian Investor model based on the published strategy of David Dreman. This contrarian strategy finds the most unpopular mid- and large-cap stocks in the market and looks for improving fundamentals.
Despite the macroeconomic impacts of the COVID-19 contagion this year, the global wearables market is still expected to grow by approximately 15% in 2020, according to recent estimates from market researcher IDC. The hearables category, which includes ear-worn smart audio devi
(RTTNews) - JetBlue (JBLU) has launched 'Be an Early Holiday-er' program, with $50 off per person on holiday flights and $300 off per flight and hotel package when booking through JetBlue Vacations for a limited time. Through September 30, 2020 customers can receive $50 off per
The future owners of Walmart's (NYSE: WMT) Asda chain of supermarkets in the U.K. have been selected. Several media outlets report the American retail giant has opted to sell its British unit to a consortium of investment management company TDR Capital and brothers Mohsin and Zu
(RTTNews) - Bristol Myers Squibb Canada or BMS and Acceleron Pharma Inc. (XLRN) said Tuesday that Health Canada has approved Reblozyl (luspatercept) for the treatment of adult patients with red blood cell (RBC) transfusion-dependent anemia associated with beta-thalassemia.